1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global TCR-T Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Autologous 1.2.3 Allogeneic 1.3 Market by Application 1.3.1 Global TCR-T Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Refractory Relapsed Melanoma 1.3.3 Synovial Sarcoma 1.3.4 Multiple Myeloma 1.3.5 Lung Cancer 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global TCR-T Therapy Market Perspective (2016-2027) 2.2 TCR-T Therapy Growth Trends by Regions 2.2.1 TCR-T Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 TCR-T Therapy Historic Market Share by Regions (2016-2021) 2.2.3 TCR-T Therapy Forecasted Market Size by Regions (2022-2027) 2.3 TCR-T Therapy Industry Dynamic 2.3.1 TCR-T Therapy Market Trends 2.3.2 TCR-T Therapy Market Drivers 2.3.3 TCR-T Therapy Market Challenges 2.3.4 TCR-T Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top TCR-T Therapy Players by Revenue 3.1.1 Global Top TCR-T Therapy Players by Revenue (2016-2021) 3.1.2 Global TCR-T Therapy Revenue Market Share by Players (2016-2021) 3.2 Global TCR-T Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by TCR-T Therapy Revenue 3.4 Global TCR-T Therapy Market Concentration Ratio 3.4.1 Global TCR-T Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by TCR-T Therapy Revenue in 2020 3.5 TCR-T Therapy Key Players Head office and Area Served 3.6 Key Players TCR-T Therapy Product Solution and Service 3.7 Date of Enter into TCR-T Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 TCR-T Therapy Breakdown Data by Type 4.1 Global TCR-T Therapy Historic Market Size by Type (2016-2021) 4.2 Global TCR-T Therapy Forecasted Market Size by Type (2022-2027) 5 TCR-T Therapy Breakdown Data by Application 5.1 Global TCR-T Therapy Historic Market Size by Application (2016-2021) 5.2 Global TCR-T Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America TCR-T Therapy Market Size (2016-2027) 6.2 North America TCR-T Therapy Market Size by Type 6.2.1 North America TCR-T Therapy Market Size by Type (2016-2021) 6.2.2 North America TCR-T Therapy Market Size by Type (2022-2027) 6.2.3 North America TCR-T Therapy Market Size by Type (2016-2027) 6.3 North America TCR-T Therapy Market Size by Application 6.3.1 North America TCR-T Therapy Market Size by Application (2016-2021) 6.3.2 North America TCR-T Therapy Market Size by Application (2022-2027) 6.3.3 North America TCR-T Therapy Market Size by Application (2016-2027) 6.4 North America TCR-T Therapy Market Size by Country 6.4.1 North America TCR-T Therapy Market Size by Country (2016-2021) 6.4.2 North America TCR-T Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe TCR-T Therapy Market Size (2016-2027) 7.2 Europe TCR-T Therapy Market Size by Type 7.2.1 Europe TCR-T Therapy Market Size by Type (2016-2021) 7.2.2 Europe TCR-T Therapy Market Size by Type (2022-2027) 7.2.3 Europe TCR-T Therapy Market Size by Type (2016-2027) 7.3 Europe TCR-T Therapy Market Size by Application 7.3.1 Europe TCR-T Therapy Market Size by Application (2016-2021) 7.3.2 Europe TCR-T Therapy Market Size by Application (2022-2027) 7.3.3 Europe TCR-T Therapy Market Size by Application (2016-2027) 7.4 Europe TCR-T Therapy Market Size by Country 7.4.1 Europe TCR-T Therapy Market Size by Country (2016-2021) 7.4.2 Europe TCR-T Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific TCR-T Therapy Market Size (2016-2027) 8.2 Asia-Pacific TCR-T Therapy Market Size by Type 8.2.1 Asia-Pacific TCR-T Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific TCR-T Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific TCR-T Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific TCR-T Therapy Market Size by Application 8.3.1 Asia-Pacific TCR-T Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific TCR-T Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific TCR-T Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific TCR-T Therapy Market Size by Region 8.4.1 Asia-Pacific TCR-T Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific TCR-T Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America TCR-T Therapy Market Size (2016-2027) 9.2 Latin America TCR-T Therapy Market Size by Type 9.2.1 Latin America TCR-T Therapy Market Size by Type (2016-2021) 9.2.2 Latin America TCR-T Therapy Market Size by Type (2022-2027) 9.2.3 Latin America TCR-T Therapy Market Size by Type (2016-2027) 9.3 Latin America TCR-T Therapy Market Size by Application 9.3.1 Latin America TCR-T Therapy Market Size by Application (2016-2021) 9.3.2 Latin America TCR-T Therapy Market Size by Application (2022-2027) 9.3.3 Latin America TCR-T Therapy Market Size by Application (2016-2027) 9.4 Latin America TCR-T Therapy Market Size by Country 9.4.1 Latin America TCR-T Therapy Market Size by Country (2016-2021) 9.4.2 Latin America TCR-T Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa TCR-T Therapy Market Size (2016-2027) 10.2 Middle East & Africa TCR-T Therapy Market Size by Type 10.2.1 Middle East & Africa TCR-T Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa TCR-T Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa TCR-T Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa TCR-T Therapy Market Size by Application 10.3.1 Middle East & Africa TCR-T Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa TCR-T Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa TCR-T Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa TCR-T Therapy Market Size by Country 10.4.1 Middle East & Africa TCR-T Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa TCR-T Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Athenex 11.1.1 Athenex Company Details 11.1.2 Athenex Business Overview 11.1.3 Athenex TCR-T Therapy Introduction 11.1.4 Athenex Revenue in TCR-T Therapy Business (2016-2021) 11.1.5 Athenex Recent Development 11.2 Xiangxue Pharmaceutical (Xiangxue Precision) 11.2.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Details 11.2.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview 11.2.3 Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Introduction 11.2.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in TCR-T Therapy Business (2016-2021) 11.2.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development 11.3 Hengrui Yuanzheng 11.3.1 Hengrui Yuanzheng Company Details 11.3.2 Hengrui Yuanzheng Business Overview 11.3.3 Hengrui Yuanzheng TCR-T Therapy Introduction 11.3.4 Hengrui Yuanzheng Revenue in TCR-T Therapy Business (2016-2021) 11.3.5 Hengrui Yuanzheng Recent Development 11.4 Eureka Therapeutics 11.4.1 Eureka Therapeutics Company Details 11.4.2 Eureka Therapeutics Business Overview 11.4.3 Eureka Therapeutics TCR-T Therapy Introduction 11.4.4 Eureka Therapeutics Revenue in TCR-T Therapy Business (2016-2021) 11.4.5 Eureka Therapeutics Recent Development 11.5 WuXi Juno 11.5.1 WuXi Juno Company Details 11.5.2 WuXi Juno Business Overview 11.5.3 WuXi Juno TCR-T Therapy Introduction 11.5.4 WuXi Juno Revenue in TCR-T Therapy Business (2016-2021) 11.5.5 WuXi Juno Recent Development 11.6 Shenzhen Inno Immunity 11.6.1 Shenzhen Inno Immunity Company Details 11.6.2 Shenzhen Inno Immunity Business Overview 11.6.3 Shenzhen Inno Immunity TCR-T Therapy Introduction 11.6.4 Shenzhen Inno Immunity Revenue in TCR-T Therapy Business (2016-2021) 11.6.5 Shenzhen Inno Immunity Recent Development 11.7 Shenzhen Binde Bio 11.7.1 Shenzhen Binde Bio Company Details 11.7.2 Shenzhen Binde Bio Business Overview 11.7.3 Shenzhen Binde Bio TCR-T Therapy Introduction 11.7.4 Shenzhen Binde Bio Revenue in TCR-T Therapy Business (2016-2021) 11.7.5 Shenzhen Binde Bio Recent Development 11.8 Kerui Bio 11.8.1 Kerui Bio Company Details 11.8.2 Kerui Bio Business Overview 11.8.3 Kerui Bio TCR-T Therapy Introduction 11.8.4 Kerui Bio Revenue in TCR-T Therapy Business (2016-2021) 11.8.5 Kerui Bio Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global TCR-T Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Autologous Table 3. Key Players of Allogeneic Table 4. Global TCR-T Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global TCR-T Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global TCR-T Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global TCR-T Therapy Market Share by Regions (2016-2021) Table 8. Global TCR-T Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global TCR-T Therapy Market Share by Regions (2022-2027) Table 10. TCR-T Therapy Market Trends Table 11. TCR-T Therapy Market Drivers Table 12. TCR-T Therapy Market Challenges Table 13. TCR-T Therapy Market Restraints Table 14. Global TCR-T Therapy Revenue by Players (2016-2021) & (US$ Million) Table 15. Global TCR-T Therapy Market Share by Players (2016-2021) Table 16. Global Top TCR-T Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TCR-T Therapy as of 2020) Table 17. Ranking of Global Top TCR-T Therapy Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by TCR-T Therapy Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players TCR-T Therapy Product Solution and Service Table 21. Date of Enter into TCR-T Therapy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global TCR-T Therapy Market Size by Type (2016-2021) (US$ Million) Table 24. Global TCR-T Therapy Revenue Market Share by Type (2016-2021) Table 25. Global TCR-T Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global TCR-T Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global TCR-T Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global TCR-T Therapy Revenue Market Share by Application (2016-2021) Table 29. Global TCR-T Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global TCR-T Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America TCR-T Therapy Market Size by Type (2016-2021) (US$ Million) Table 32. North America TCR-T Therapy Market Size by Type (2022-2027) & (US$ Million) Table 33. North America TCR-T Therapy Market Size by Application (2016-2021) (US$ Million) Table 34. North America TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million) Table 35. North America TCR-T Therapy Market Size by Country (2016-2021) & (US$ Million) Table 36. North America TCR-T Therapy Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe TCR-T Therapy Market Size by Type (2016-2021) (US$ Million) Table 38. Europe TCR-T Therapy Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe TCR-T Therapy Market Size by Application (2016-2021) (US$ Million) Table 40. Europe TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe TCR-T Therapy Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe TCR-T Therapy Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific TCR-T Therapy Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific TCR-T Therapy Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific TCR-T Therapy Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific TCR-T Therapy Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific TCR-T Therapy Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America TCR-T Therapy Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America TCR-T Therapy Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America TCR-T Therapy Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America TCR-T Therapy Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America TCR-T Therapy Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa TCR-T Therapy Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa TCR-T Therapy Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa TCR-T Therapy Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa TCR-T Therapy Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa TCR-T Therapy Market Size by Country (2022-2027) & (US$ Million) Table 61. Athenex Company Details Table 62. Athenex Business Overview Table 63. Athenex TCR-T Therapy Product Table 64. Athenex Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million) Table 65. Athenex Recent Development Table 66. Xiangxue Pharmaceutical (Xiangxue Precision) Company Details Table 67. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview Table 68. Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Product Table 69. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million) Table 70. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development Table 71. Hengrui Yuanzheng Company Details Table 72. Hengrui Yuanzheng Business Overview Table 73. Hengrui Yuanzheng TCR-T Therapy Product Table 74. Hengrui Yuanzheng Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million) Table 75. Hengrui Yuanzheng Recent Development Table 76. Eureka Therapeutics Company Details Table 77. Eureka Therapeutics Business Overview Table 78. Eureka Therapeutics TCR-T Therapy Product Table 79. Eureka Therapeutics Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million) Table 80. Eureka Therapeutics Recent Development Table 81. WuXi Juno Company Details Table 82. WuXi Juno Business Overview Table 83. WuXi Juno TCR-T Therapy Product Table 84. WuXi Juno Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million) Table 85. WuXi Juno Recent Development Table 86. Shenzhen Inno Immunity Company Details Table 87. Shenzhen Inno Immunity Business Overview Table 88. Shenzhen Inno Immunity TCR-T Therapy Product Table 89. Shenzhen Inno Immunity Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million) Table 90. Shenzhen Inno Immunity Recent Development Table 91. Shenzhen Binde Bio Company Details Table 92. Shenzhen Binde Bio Business Overview Table 93. Shenzhen Binde Bio TCR-T Therapy Product Table 94. Shenzhen Binde Bio Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million) Table 95. Shenzhen Binde Bio Recent Development Table 96. Kerui Bio Company Details Table 97. Kerui Bio Business Overview Table 98. Kerui Bio Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million) Table 99. Kerui Bio Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global TCR-T Therapy Market Share by Type: 2020 VS 2027 Figure 2. Autologous Features Figure 3. Allogeneic Features Figure 4. Global TCR-T Therapy Market Share by Application: 2020 VS 2027 Figure 5. Refractory Relapsed Melanoma Case Studies Figure 6. Synovial Sarcoma Case Studies Figure 7. Multiple Myeloma Case Studies Figure 8. Lung Cancer Case Studies Figure 9. Other Case Studies Figure 10. TCR-T Therapy Report Years Considered Figure 11. Global TCR-T Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global TCR-T Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global TCR-T Therapy Market Share by Regions: 2020 VS 2027 Figure 14. Global TCR-T Therapy Market Share by Regions (2022-2027) Figure 15. Global TCR-T Therapy Market Share by Players in 2020 Figure 16. Global Top TCR-T Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TCR-T Therapy as of 2020 Figure 17. The Top 10 and 5 Players Market Share by TCR-T Therapy Revenue in 2020 Figure 18. Global TCR-T Therapy Revenue Market Share by Type (2016-2021) Figure 19. Global TCR-T Therapy Revenue Market Share by Type (2022-2027) Figure 20. North America TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America TCR-T Therapy Market Share by Type (2016-2027) Figure 22. North America TCR-T Therapy Market Share by Application (2016-2027) Figure 23. North America TCR-T Therapy Market Share by Country (2016-2027) Figure 24. United States TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe TCR-T Therapy Market Share by Type (2016-2027) Figure 28. Europe TCR-T Therapy Market Share by Application (2016-2027) Figure 29. Europe TCR-T Therapy Market Share by Country (2016-2027) Figure 30. Germany TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific TCR-T Therapy Market Share by Type (2016-2027) Figure 38. Asia-Pacific TCR-T Therapy Market Share by Application (2016-2027) Figure 39. Asia-Pacific TCR-T Therapy Market Share by Region (2016-2027) Figure 40. China TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America TCR-T Therapy Market Share by Type (2016-2027) Figure 48. Latin America TCR-T Therapy Market Share by Application (2016-2027) Figure 49. Latin America TCR-T Therapy Market Share by Country (2016-2027) Figure 50. Mexico TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa TCR-T Therapy Market Share by Type (2016-2027) Figure 54. Middle East & Africa TCR-T Therapy Market Share by Application (2016-2027) Figure 55. Middle East & Africa TCR-T Therapy Market Share by Country (2016-2027) Figure 56. Turkey TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Athenex Revenue Growth Rate in TCR-T Therapy Business (2016-2021) Figure 60. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue Growth Rate in TCR-T Therapy Business (2016-2021) Figure 61. Hengrui Yuanzheng Revenue Growth Rate in TCR-T Therapy Business (2016-2021) Figure 62. Eureka Therapeutics Revenue Growth Rate in TCR-T Therapy Business (2016-2021) Figure 63. WuXi Juno Revenue Growth Rate in TCR-T Therapy Business (2016-2021) Figure 64. Shenzhen Inno Immunity Revenue Growth Rate in TCR-T Therapy Business (2016-2021) Figure 65. Shenzhen Binde Bio Revenue Growth Rate in TCR-T Therapy Business (2016-2021) Figure 66. Kerui Bio Revenue Growth Rate in TCR-T Therapy Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Athenex Xiangxue Pharmaceutical (Xiangxue Precision) Hengrui Yuanzheng Eureka Therapeutics WuXi Juno Shenzhen Inno Immunity Shenzhen Binde Bio Kerui Bio